We are live on ! Find out more

Invesco Dorsey Wright Healthcare Momentum ETF

PTH

Market cap $284M

60.74 USD

-0.06

0.1%

At close Updated Sep 16, 4:00 PM EDT

1 day

-0.1%

5 days

-0.39%

1 month

-0.2%

3 months

17.24%

6 months

26.83%

Year to date

23.35%

1 year

54.05%

5 years

6.86%

10 years

259.2%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 100%

Neutral 0%

Negative 0%

Zacks Investment Research

Should You Invest in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Invesco Dorsey Wright Healthcare Momentum ETF (PTH), a passively managed exchange traded fund launched on October 12, 2006.

Should You Invest in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH)?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Medical Technology Stocks: Innovation Endures As Valuations Reset

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Can Forgotten Biotech Break Out?

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Investing In Health Stocks - How Policy Clarity Is Opening Doors

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Healthcare Sector Checkup As U.S. Looks To Change Regulations

PTH: A Health Care Headache Worth Selling

PTH is comprised of 30+ Health Care stocks selected based on a proprietary momentum-based model. Its expense ratio is 0.60% and the ETF has $115 million in assets under management. The strategy relies on technical analysis, but that's not necessarily the issue. Instead, PTH reconstitutes quarterly, forcing managers to wait to buy stocks only after they've made their massive gains. PTH's current holdings illustrate this point perfectly. Although they've gained 51% over the last six months, the ETF itself has declined by 12% over the same period.

PTH: A Health Care Headache Worth Selling

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Zacks Investment Research

Unwrapping 5 ETF Surprises From Secret Santa for Christmas

The current dip has made many ETFs attractive, and we call them "Secret Santa." These could surprise investors with big returns this Christmas.

Unwrapping 5 ETF Surprises From Secret Santa for Christmas

Finding Opportunity in Unloved Healthcare ETFs

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

See News Rankings

Price charts implemented using Lightweight Charts™